Cognition Therapeutics Inc
Biological Products, (No Diagnostic Substances) · Purchase, NY, United States
- PrincipalsAnthony CaggianoChief Medical OfficerJohn Brendan DoyleChief Financial OfficerLisa RicciardiCEO & President
- CompanyCognition Therapeutics IncPurchase, NY, United States
- Phone line+1 (412) 481-2210General business
Cognition Therapeutics Inc is an SEC-registered Nasdaq-listed company (ticker CGTX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions
People 3
Chief executive
Lisa RicciardiCEO & President
Finance
John Brendan DoyleChief Financial Officer
Everyone else on file (1)
Anthony CaggianoChief Medical Officer
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Anthony Caggiano — Chief Medical Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗John Brendan Doyle — Chief Financial Officer
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Lisa Ricciardi — CEO & President
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
Crispr Therapeutics AGBiological Products, (No Diagnostic Substances) · Zug1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityTarget Group Inc.Medicinal Chemicals & Botanical Products · Hamilton1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capability